Program og præsentationer 2018

13:00
Velkommen
Anne Bukh, forman for styregruppen i DCCC, koncerndirektør, Region Nordjylland

13:15
Nationalt samarbejde
Ordstyrer: Cai Grau

• Nationalt Forskningscenter for Immunterapi
  Inge Marie Svane, professor, leder af Nationalt Forskningscenter for Cancer Immunterapi
  
  
• Nationale forskningscentre for senfølger
  Peter Christensen, professor, Nationale Forskningscenter for Senfølger til kræft i bækkenorganerne 
  Peer Christiansen, professor, leder af Nationalt Center for Brystkræftsenfølger
  Christoffer Johansen, professor, leder af Center for Senfølger hos kræftoverlevere: CASTLE
  
  
• Nationalt Forskningscenter for Stråleterapi
  Cai Grau, professor, leder af Nationalt Forskningscenter for Stråleterapi
  
  
• Nationalt Genom Center
  Gert Sørensen, direktør, Nationalt Genom Center under Sundheds- og Ældreministeriet
  
  
• Sundhedsstyrelsens planer og aktiviteter inden for Kræftområdet
  Astrid Nørgaard, sektionsleder for Sygehusplanlægning, kræft og rehabilitering
  
  
• Paneldebat med oplægsholderne og Anne Bukh, formand for styregruppen i DCCC
  Moderator Jesper Fisker, adm. direktør, Kræftens Bekæmpelse

15:00
Netværkspause

15:30
Patienter i kliniske studier
Ordstyrer: Michael Borre

• Nødvendigheden af patientinvolveret klinisk forskning
  Jens Overgaard, professor, Afd. for Eksperimentel Klinisk Onkologi og Kræftafdelingen, Aarhus Universitetshospital
  
  
• Patienter i kliniske studier; erfaringer fra Dansk Bryst Cancer Gruppe
  Birgitte Vrou Offersen, professor, Afd. for Eksperimentel Klinisk Onkologi og Kræftafdelingen, Aarhus Universitetshospital
  
  
• Klinisk forskning fra patientens synspunkt
  Peter Ringsted, konsulent, cand.jur., patient
  
  
• Klinisk forskning og udvikling i den daglige drift
  Poul-Erik Svendsen, næstformand for Sundhedsudvalget, Danske Regioner og formand for Sundhedsudvalget, Region Syddanmark
  
  
• Paneldebat med oplægsholderne samt Henrik Ullum, formand for Lægevidenskabelige Selskaber (LVS)
  Moderator Michael Borre, professor, formand for DMCG.dk

17:00
Præsentation af postersession
Jens Overgaard, professor, Afd. for Eksperimentel Klinisk Onkologi og Kræftafdelingen, Aarhus Universitetshospital

17:15 – 19:00
Postersession & markedsplads

17:30 – 19:00
Foredrag: Immunterapi i øjenhøjde
Inge Marie Svane, professor,leder af Center for Cancer Immunterapi
Lars Bastholt, overlæge, Onkologisk afdeling, Odense Universitetshospital
Lærke Kjær Tolstrup, ph.d.-studerende, onkologisk sygeplejerske

19:30 – 21:00
Netværksmiddag 

08:15
Good morning and a short recap
Michael Borre, Professor, Chair of Danish Multidisciplinary Cancer Groups(DMCG.dk)

08:30
From basic science to clinical research (presentations not available)
Chair: Kristian Helin

• Understanding and targeting stress-associated cancer cell vulnerabilities
  Jiri Bartek, Professor, Danish Cancer Society
  
  
• Epigenetic dysfunction in AML: H3K27 as a key nexus for transformation and therapy
  Brian Huntly, Professor, Cambridge Institute for Medical Research, Department of Haematology
  
  
• Bringing scientific discoveries to patients quickly and cheaply
  René Bernards, Professor, Division of Molecular Carcinogenesis, The Netherlands Cancer Institute
  
  
• Panel discussion with presenters and Kristian Helin, Professor, BRIC, Sloan Kettering Institute 
  Moderator Morten Mau-Sørensen, Chief Physician, The Phase I Unit, Rigshospitalet

10:00
Networking coffee and tea

10:30
The unique use of Danish registries in cancer research
Chair: Jens Winther Jensen

• Important discoveries in cancer epidemiology derive from research based on our national registries and biobanks (presentation not available)
  Henrik Hjalgrim, Chief Physician, MD, Department of Epidemiology Research at Statens Serum Institut
  
  
• Linkages to enhance population-based cohort data
  Anne Tjønneland, Professor, Head of Research at Diet, Genes and Environment, Danish Cancer Society Research Center
  
  
• Variation in pancreas cancer treatment and associated survival: England and Denmark (presentation not available)
  Henrik Møller, Professor, Lead Epidemiologist at The Danish Clinical Registries (RKKP)
  
  
• The use of Danish prescription, pathology and laboratory databases in cancer research
  Mette Nørgaard, Professor, Consultant, MD, PhD, Department of Clinical Epidemiology, Aarhus University Hospital
  
  
• Panel discussion with presenters and Erik Jylling, Executive Vice President Health Politics, Danish Regions
  Moderator Jens Winther Jensen, Director, The Danish Clinical Registries (RKKP)

12:00
Lunch and networking

13:00
Poster awards with short presentations
Chair: Mef Nilbert, Professor, Research Director, Danish Cancer Society
Poster award winner: Mette Tranberg & Siv Lykke Jørgensen

13:30
Comprehensive, translational cancer research – an international perspective (presentation not available)
Chair: Jens Overgaard
Key note address Michael Baumann, Professor, Director German Cancer Research Center (DKFZ), Heidelberg

14:15
Infrastructure and strategies for precision medicine: leukaemias, solid tumor and beyond
Chair: Jens Overgaard
Key note address Olli-Pekka Kallioniemi, Professor of Molecular Medicine at the Karolinska Institute, Director of the Science for Life Laboratory

14:45
Closing remarks
Cai Grau, Chair of the Scientific Council, DCCC, Professor